Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple
暂无分享,去创建一个
D. Sahoo | I. Kufareva | M. Ghassemian | Nicholas A. Kalogriopoulos | N. Aznar | Ying Dunkel | Kendall Satterfield | Fanghui He | Inmaculada López-Sánchez | P. Ghosh | J. Ear | Nina N. Sun | Inmaculada López-Sánchez | Jason Ear
[1] M. Stack,et al. Wnt5a Signaling in Cancer , 2016, Cancers.
[2] Chih-Pin Chuu,et al. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling , 2016, Oncotarget.
[3] Guoxin Zhang,et al. FZD6, targeted by miR-21, represses gastric cancer cell proliferation and migration via activating non-canonical wnt pathway. , 2016, American journal of translational research.
[4] Jiwang Zhang,et al. Osteopontin—A Master Regulator of Epithelial-Mesenchymal Transition , 2016, Journal of clinical medicine.
[5] K. Janssen,et al. Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer , 2016, Scientific Reports.
[6] Q. Ye,et al. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin , 2016, Oncotarget.
[7] Debashis Sahoo,et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. , 2016, The New England journal of medicine.
[8] Suyun Huang,et al. Crosstalk of the Wnt/β-catenin pathway with other pathways in cancer cells , 2016, Genes & diseases.
[9] Y. Kodera,et al. Role for Daple in non‐canonical Wnt signaling during gastric cancer invasion and metastasis , 2015, Cancer Science.
[10] J. N. Anastas. Functional Crosstalk Between WNT Signaling and Tyrosine Kinase Signaling in Cancer. , 2015, Seminars in oncology.
[11] W. Hiddemann,et al. A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia , 2015, British journal of haematology.
[12] Bert Vogelstein,et al. The Path to Cancer --Three Strikes and You're Out. , 2015, The New England journal of medicine.
[13] K. Willert,et al. Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling , 2015, eLife.
[14] Qiang Wang,et al. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer , 2015, Cancer biology & therapy.
[15] T. Wood,et al. Crosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast Cancer , 2015, Front. Endocrinol..
[16] Mei-rong Zhao,et al. Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy , 2015, Cancer biology & therapy.
[17] S. Cagnol,et al. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer , 2014, Oncogene.
[18] R. Abagyan,et al. Structural basis for activation of trimeric Gi proteins by multiple growth factor receptors via GIV/Girdin , 2014, Molecular biology of the cell.
[19] E. Llamosas,et al. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. , 2014, Gynecologic oncology.
[20] Baocun Sun,et al. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer. , 2014, Oncology reports.
[21] G. Schulte,et al. Disheveled regulates precoupling of heterotrimeric G proteins to Frizzled 6 , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] J. Clements,et al. PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer , 2014, Clinical & Experimental Metastasis.
[23] M. Gentzel,et al. β-Arrestin Interacts with the Beta/Gamma Subunits of Trimeric G-Proteins and Dishevelled in the Wnt/Ca2+ Pathway in Xenopus Gastrulation , 2014, PloS one.
[24] Wei Zhang,et al. Heterotrimeric G-Protein, Gα16, Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer , 2013, PloS one.
[25] Zhen Xu,et al. The structure of the Tiam1 PDZ domain/ phospho-syndecan1 complex reveals a ligand conformation that modulates protein dynamics. , 2013, Structure.
[26] F. E. Bertrand,et al. Developmental pathways in colon cancer , 2012, Cell cycle.
[27] D. Birnbaum,et al. A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III. , 2012, Omics : a journal of integrative biology.
[28] L. Kirkeby,et al. Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature , 2012, International Journal of Colorectal Disease.
[29] Dihua Yu,et al. Growth factor signaling in metastasis: current understanding and future opportunities , 2012, Cancer and Metastasis Reviews.
[30] Y. Murakumo,et al. The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility , 2012, Nature Communications.
[31] Ruben Abagyan,et al. Pocketome: an encyclopedia of small-molecule binding sites in 4D , 2011, Nucleic Acids Res..
[32] Pradeep S Rajendran,et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.
[33] Miranda Thomas,et al. PDZ domains: the building blocks regulating tumorigenesis. , 2011, The Biochemical journal.
[34] R. Abagyan,et al. Tyrosine Phosphorylation of the Gα-Interacting Protein GIV Promotes Activation of Phosphoinositide 3-Kinase During Cell Migration , 2011, Science Signaling.
[35] M. Farquhar,et al. G Protein Binding Sites on Calnuc (Nucleobindin 1) and NUCB2 (Nucleobindin 2) Define a New Class of Gαi-regulatory Motifs* , 2011, The Journal of Biological Chemistry.
[36] M. Farquhar,et al. A GDI (AGS3) and a GEF (GIV) regulate autophagy by balancing G protein activity and growth factor signals , 2011, Molecular biology of the cell.
[37] M. Katoh. Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. , 2011, Current pharmaceutical biotechnology.
[38] Linheng Li,et al. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. , 2010, Birth defects research. Part C, Embryo today : reviews.
[39] M. Rots,et al. EpCAM in carcinogenesis: the good, the bad or the ugly. , 2010, Carcinogenesis.
[40] J. Carethers,et al. A Gαi–GIV Molecular Complex Binds Epidermal Growth Factor Receptor and Determines Whether Cells Migrate or Proliferate , 2010, Molecular biology of the cell.
[41] Hong-Jian Zhu,et al. Proteomics Profiling of Madin-Darby Canine Kidney Plasma Membranes Reveals Wnt-5a Involvement during Oncogenic H-Ras/TGF-β-mediated Epithelial-Mesenchymal Transition* , 2010, Molecular & Cellular Proteomics.
[42] T. Yeatman,et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. , 2010, Gastroenterology.
[43] M. Farquhar,et al. A Structural Determinant That Renders Gαi Sensitive to Activation by GIV/Girdin Is Required to Promote Cell Migration* , 2010, The Journal of Biological Chemistry.
[44] T. Ørntoft,et al. Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer , 2009, Clinical Cancer Research.
[45] E. Komives,et al. Interactions of the NPXY microdomains of the low density lipoprotein receptor‐related protein 1 , 2009, Proteomics.
[46] E. Jho,et al. Negative feedback regulation of Wnt signaling by Gβγ-mediated reduction of Dishevelled , 2009, Experimental & Molecular Medicine.
[47] V. Katanaev,et al. The trimeric G protein Go inflicts a double impact on axin in the Wnt/frizzled signaling pathway , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[48] M. Farquhar,et al. GIV is a Non-Receptor GEF for G{alpha}i with a Unique Motif that Regulates Akt Signaling , 2009 .
[49] M. Farquhar,et al. GIV is a nonreceptor GEF for Gαi with a unique motif that regulates Akt signaling , 2009, Proceedings of the National Academy of Sciences.
[50] R. Hannoush,et al. Inhibition of Wnt signaling by Dishevelled PDZ peptides. , 2009, Nature chemical biology.
[51] P. Sternberg,et al. Ror receptor tyrosine kinases: orphans no more. , 2008, Trends in cell biology.
[52] Robert Tibshirani,et al. Boolean implication networks derived from large scale, whole genome microarray datasets , 2008, Genome Biology.
[53] M. Farquhar,et al. Activation of Gαi3 triggers cell migration via regulation of GIV , 2008, The Journal of cell biology.
[54] S. Rees,et al. Antibodies that identify only the active conformation of Gi family G protein α subunits , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] Kosuke Yanai,et al. Crosstalk of hedgehog and Wnt pathways in gastric cancer. , 2008, Cancer letters.
[56] T. Pukrop,et al. The complex pathways of Wnt 5a in cancer progression , 2008, Journal of Molecular Medicine.
[57] M. Katoh,et al. Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells. , 2007, International journal of molecular medicine.
[58] Sung-Eun Kim,et al. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. , 2007, Cellular signalling.
[59] Gordon B. Mills,et al. Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity* , 2007, Journal of Biological Chemistry.
[60] S. Weiss,et al. A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells , 2006, Nature Cell Biology.
[61] T. Asahara,et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. , 2006, Cancer research.
[62] M. MacCoss,et al. Molecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machinery , 2006, Nature.
[63] M. Ueno,et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] Jun Qin,et al. Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .
[65] S. Jeon,et al. Both ERK and Wnt/β-catenin pathways are involved in Wnt3a-induced proliferation , 2005, Journal of Cell Science.
[66] T. Noda,et al. MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap , 2004, Oncogene.
[67] R. Nusse,et al. Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.
[68] T. Asahara,et al. Identification and characterization of a novel Dvl‐binding protein that suppresses Wnt signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[69] Tony Hunter,et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. , 2003, Cancer cell.
[70] M. Luca,et al. CaMKII-dependent Phosphorylation Regulates SAP97/NR2A Interaction* , 2003, Journal of Biological Chemistry.
[71] K. Moelling,et al. The Bcr Kinase Downregulates Ras Signaling by Phosphorylating AF-6 and Binding to Its PDZ Domain , 2003, Molecular and Cellular Biology.
[72] Nobuyuki Onishi,et al. The receptor tyrosine kinase Ror2 is involved in non‐canonical Wnt5a/JNK signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.
[73] Kevin L. Shaw,et al. Tyrosine hydrogen bonds make a large contribution to protein stability. , 2001, Journal of molecular biology.
[74] L. Norton,et al. The Epidermal Growth Factor Receptor Modulates the Interaction of E-cadherin with the Actin Cytoskeleton* , 1998, The Journal of Biological Chemistry.
[75] J. Yates,et al. Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. , 1997, Analytical chemistry.
[76] H. Bedouelle,et al. Energetic and kinetic contributions of contact residues of antibody D1.3 in the interaction with lysozyme. , 1997, Biochemistry.
[77] Solomon H. Snyder,et al. Binding of the Inward Rectifier K+ Channel Kir 2.3 to PSD-95 Is Regulated by Protein Kinase A Phosphorylation , 1996, Neuron.
[78] R Abagyan,et al. Homology modeling by the ICM method , 1995, Proteins.
[79] S. Stricker,et al. ROR-Family Receptor Tyrosine Kinases. , 2017, Current topics in developmental biology.
[80] D. Sahoo,et al. CDX 2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer , 2016 .
[81] Min-Sung Kim,et al. Transient mammalian cell transfection with polyethylenimine (PEI). , 2013, Methods in enzymology.
[82] Josep Tabernero,et al. EGFR and KRAS in colorectal cancer. , 2010, Advances in clinical chemistry.
[83] T. Asahara,et al. Expression of Wnt-5 a Is Correlated with Aggressiveness of Gastric Cancer by Stimulating Cell Migration and Invasion , 2006 .